English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 13 Help

Selected(0)Clear Items/Page:    Sort:
Research and development of hepatitis b drugs: an analysis based on technology flows measured by patent citations Book chapter
出自: Innovation Value Chain Of Chinese Pharmaceuticals:United States-China Intellectual Property Institute Inc., 2017, 页码:159-186
Authors:  Huang, CJ;  Lin, HH;  Wan, JB;  He, CW;  Hu, YJ
Favorite |  | Submit date：2022/08/07
Monitoring drug research on clinical neurology in China: An analysis of institutional leaders and community themes Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:53-72
Authors:  Ka Weng Si Tou;  Jianbo Wan;  Marvin S.H. Mak;  Yifan Han;  Yuanjia Hu
Favorite |  | Submit date：2019/01/14
Neurological Drugs  Thematic Analysis  Greater China  Publications  Research Collaboration Networks  
China’s landscape of discovering miRNAs in cancer Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:73-90
Authors:  Hengwa Kuok;  Xiangjun Kong;  Yuanjia Hu;  Yitao Wang
Favorite |  | Submit date：2019/01/14
Global landscape of research and development on antibiotics Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:91-114
Authors:  Xiangjun Kong;  Hong Lu;  Qianru Zhang;  Huali Zuo;  Yuanjia Hu; et al.
Favorite |  | Submit date：2019/01/14
Innovation Value Chain of Chinese Pharmaceuticals Book
Yitao Wang, Yuanjia Hu, Albert Wai-Kit Chan. Innovation Value Chain of Chinese Pharmaceuticals[M]. 141-07 20th Avenue World Plaza, Suite 604 Whitestone, NY 11357:United States-China Intellectual Property Institute Inc., 2017, 286.
Authors:  Yitao Wang;  Yuanjia Hu;  Albert Wai-Kit Chan
Favorite |  | Submit date：2019/01/14
China  Pharmaceutical Industry  Obstacles  Opportunities  Global Network  Innovation  
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu; et al.
Favorite |  | Submit date：2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network  
An analysis of technology flows of antidepressants based on patent citation network Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:187-208
Authors:  Siqi Tian;  Hui Heng Lin;  Marvin S.H. Mak;  Yifan Han;  Yuanjia Hu
Favorite |  | Submit date：2019/01/14
Entry inhibitors for AIDS therapy: A review of research and development projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:115-134
Authors:  Xiangjun Kong;  Hongyu Liang;  Qingwen Yuan;  Yuanjia Hu
Favorite |  | Submit date：2019/01/14
Pharmaceutical patent valuation based on empirical models Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:209-220
Authors:  Jingyun Ni;  Rong Shao;  Carolina Oi Lam Ung;  Yitao Wang;  Yuanjia Hu; et al.
Favorite |  | Submit date：2019/01/14
Pharmaceutical Patents  Patent Value  Valuation  Echnological Factors  Commercial Factors  Legal Factors  
Pharmaceutical innovation network: Global patterns and the role of China Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:259-281
Authors:  Pengpeng Li;  Huiheng Lin;  Yuanjia Hu
Favorite |  | Submit date：2019/01/15
Pharmaceutical Innovation  Drug Patents  Network Analysis